Take your head out of the sand on China: a Perspective

The ability of U.S. biotech executives, policymakers and some investors to deny the rising innovation and inventiveness from China is astonishing. But no degree of protectionism, and no willing it away, is going to change the reality that the U.S. is facing ever-increasing competition from a new geographic center of excellence, and — barring a dramatic change in policy and pace — that it’s going to lose some or even most of its biotech dominance.

Moreover, this is good for patients...